Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News PRISM BioLab and Talus Bioscience aim to crack the transcription factor code with dual-platform drug discovery strategy PRISM BioLab and Talus Bio have teamed up to crack transcription factor drug discovery. Find out how their dual-platform strategy could reshape precision medicine. byVenkateshDecember 18, 2025